ESTUDIO DE LA INFORMACIÓN ENTRE CLÍNICOS Y PATÓLOGOS

Linfomas No Hodgkin

Josep Gumà Padró


[Objetivos] [Introducción] [Tratamientos Estándar] [L.Altamente Agresivos] [L.Foliculares] [L.Linfocitico] [L.Manto] [Linfoma T NOS] [L.MALT] [L.C.G.Mediastino] [L.Anaplásico] [L.Linfoblástico] [L.Burkitt-Like] [Linfomas Varios] [Conclusiones] [Bibliografía] [Autoevaluación]

BIBLIOGRAFÍA

    GENERAL

  1. The Non-hodgkin's lymphoma pathologic classification project: National Cancet Institute sponsored study of classifications of non-hodgkin's lymphomas.Sumary and description of a Working Formulation for clinical usage. Cancer 49:2112-2135, 1982.
  2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al: A Revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood 84: 1361-92. 1994.
  3. Armitage JO, Weisenburger DD for The Non-Hodgkin’s Lymphoma Classification Project: New approach to classifying non-Hodgkin’s lymphomas: Clinical features of the major histologic subtypes. J Clin Oncol 16: 2780-95. 1998.
  4. Fisher RI, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328: 1002-6. 1993.
  5. Fisher RI. Treatment of aggressive non-Hodgkin’s lymphomas. Cancer 74:2657-61. 1994.
  6. Miller TP, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin’s lymphoma. N Engl J Med 339: 21-6. 1998.
  7. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329: 987-94.1993.
  8. López-Guillermo A, et al: Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12:1343-8. 1994.
  9. Carbone PP,Kaplan HS,MusshoffK et al:Report of the committee on Hodgkin's disease staging. Cancer Res 31: 1860-1. 1971.
  10. Porcu P, Nichols CR: Evaluation and management of the "New lymphoma entities: Mantle cell lymphoma, lymphoma of mucosa-asociated lymphoid tissue, anaplastic large-cel lymphoma, and primary mediastinal B-cell lymphoma. Curr Probl Cancer 3: 1-92. 1999.
  11. Hall PA, Richards MA, Gregory WM, d’Ardenne AJ, Lister TA, Stansfeld AG: The prognostic value of Ki67 immunostaining in non-Hodgkin’s lymphoma. J Pathol 154: 223-35. 1988.
  12. Veneroni S, Costa A, Motta R, Giardini R, Rilke F, Silvestrini R: Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin’s lymphomas. Hematol Oncol 6: 21-8. 1988.
  13. Gerdes J, Dallenbach F, Lennert K: Growth fractions in malignant non-Hodgkin’s lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67: Hematol Oncol 2: 365-71. 1984.
  14.  

    LINFOMA DIFUSO DE CÉLULAS GRANDES

  15. Hodges GF, Lenharrdt TM, Cotelingam JD: Bone marrow involvement in large-cell lymphoma. Prognostic implications of discordant disease. Am J Clin Pathol 101: 305-11. 1994.
  16. Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, et al: Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin’s lymphomas: A prospective Southwest Oncology Group Trial. Blood 83:1460-6. 1994.
  17. Robertson LE, Redman JR, Butler JJ, Osborne BM, Velasquez WS, McLaughlin P, et al: Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse. J Clin Oncol 9: 236-42. 1991.
  18. Kramer MHH, Parker HJ, Krol ADG, Kluin-Nelemans JC, Haak HL, van Groningen K, et al: Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study. J Clin Oncol 14: 2131-8. 1996.
  19. Offit K, Lo Coco F, Louie DC, et al: Rearrangement of the bcl-6 gene as a prognostic marker in diffusse large-cell lymphoma. N Engl J Med 331: 74-80. 1994.
  20. Gascoyne RD, Adomat SA, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, et al: Prognostic sugnificance of bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin’s lymphoma: Blood 90: 244-51. 1997.
  21. Hermine O, Haioun C, Lepage E, D’Agay MF, Briere J, Lavignac C, et al: Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin’s lymphoma. Blood 87: 265-272. 1996.

  22. LINFOMAS FOLICULARES

  23. Horning SJ: Natural history of and therapy for the indolent non-Hodgkin’s lymphomas. Semin Oncol 20 (Suppl 5): 75-88. 1993.
  24. Grogan TM, et al: Immunobiologic correlates of prognosis in lymphoma. Semin Oncol 20 (Suppl 5): 58-74. 1993.
  25. Longo DL: What's the deal with follicular lymphoma. J Clin Oncol 11:202-8. 1993.
  26. Multani PS, Grossbard ML: Monoclonal antibody-based therapies for hematologic malignancies. J Clin Oncol 16: 3691-710. 1998.
  27. Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D, et al: Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 92: 1927-32. 1998.
  28. Maloney DG, Grillo-López AJ, Bodkin DJ, White CA, Liles T-M, Royston I, et al: IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin’s lymphoma. J Clin Oncol 15: 3266-74. 1997.
  29. Maloney DG, Grillo-López AJ, White CA, Bodkin DJ, Schilder RJ, Neidhart JA, et al: IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood 90: 2188-95. 1997.
  30. Czuczman MS, Grillo-López AJ, White CA, Saleh M, Gordon L, LoBuglio AF, et al: Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17: 268-76. 1999.
  31. Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med 311:1471-5. 1984.

  32. LINFOMA LINFOCÍTICO DE CÉLULAS PEQUEÑAS / LLC

  33. Ben-Ezra J, Burke JS, Swartz WG, Brownwll MD, Brynes RK, Hill LR, et al:Small Lymphocytic lymphoma: A clinicopathologic analysis of 268 cases. Blood 73: 579-87. 1989.
  34. Rozman C, Montserrat E: Chronic Lymphocytic Leukemia. N engl J Med 333:1052-7. 1995.
  35. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S, et al: National Cancer Institute-Sponsored Working Group guidelines for Chronic Lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87:4990-7. 1996.
  36. Evans H, Butler J, Youness E: Malignant lymphoma, small lymphocytic type: a clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma. Cancer 41:1440. 1977.
  37. Pugh W, Manning J, Butler J: Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia. Am J Surg pathol 12: 907. 1998.
  38. Engelhard M, Brittinger G, Heinz R, et al: Cronyc lymphocytic Leukemia (B-CLL) and immunocytoma (LP-IC):clinical and prognostic relevance of this distinction. Leuk Lymphoma (suppl) 161. 1991.
  39. Catovsky AED, O´Brien MO, Cerchi M, Kumaran TO, Galton DAG: "Prolymphocytoid" transformation of chronic lymphocytic leukemia.Br J Haematol 41: 9. 1979.
  40. O’Brien A, del Giglio A, Keating M. Advances in the biology and treatmet of B-cell chronic lymphocytic leukemia. Blood 85:307. 1995.

  41. LINFOMA DIFUSO DE CÉLULAS GRANDES PRIMARIO DE MEDIASTINO

  42. Abou-Elella AA, Weisenburger DD, Vose JM, Kollath JP, Lynch JC, Bast MA, et al: Primary mediastinal Large B-cell lymphoma: A clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol 17: 784-90. 1999.
  43. Perrone T, Frizzera G, Rosai J: Mediastinal diffuse large-cell lymphoma with sclerosis: A clinicopathologic study of 60 cases. Am J Surg Pathol 103:176-91. 1986
  44. Cazals-Hatem D, Lepage E, Brice P, et al: Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas_A GELA (Groupe d’Etude des Lymphomes de l’Adulte") study. Am J Surg Pathol 20:877-88. 1996.
  45. Lichenstein AK, Levine A, Taylor CR, et al: Primary mediastinal lymphoma in adults. Am J Med 68:509-14. 1980.
  46. Lazzarino M, Orlandi E, Paulli M, et al: Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients. J Clin Oncol 15:1646-53. 1997.

  47. LINFOMA DE CÉLULAS DEL MANTO

  48. Weisenburger DD, Linder J, Daley DT, Armitage JO: Intermediate lymphocytic lymphoma: An Immunohistologic study with comparison to other lymphocytic lymphomas. Hum Patjol 18:781-90. 1987.
  49. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, Meerwaldt JH, Hagenbeek A, van Glaggeke M, et al: Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with other non-Hodgkin’s lymphoma subtypes. J Clin Oncol 13: 2819-26. 1995.
  50. Meusers P, Engelhard M, Bartels H, Binder H, Fülle HH, Görg K, et al: Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: antracycline does not improve prognosis. Hematol Oncol 7: 365-80. 1989.
  51. Leith CP, Spiet CM, Grogan TM, Gonzales G, Rangel CS, Rybski JA, et al: Diffuse small cleaved-cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets. J Clin Oncol 10: 1259-65. 1992.
  52. Shivdasani R, Hess JL, Skarin AT, Pinkus GS: Intermediate lymphocytic lymphoma: Clinical and pathologic features of a recently characterized subtype of non-Hodgkin’s lymphoma. J Clin Oncol 11: 802-11. 1993.
  53. Zukerberg L,Jeffrey L, Medeiros L, Ferry JA, Harris NL: Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 100: 373-85. 1993.
  54. Velders GA, Kluin-Nelemans JC, De Boer CJ, Hermans J, Noordijk EM, Schuuring E, et al: Mantle-cell lymphoma: A population-based clinical study. J Clin Oncol 14: 1269-74. 1996.
  55. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM: A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the Mucosa-Associated Lymphoid Tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study. Blood 85: 1075-82. 1995.
  56. Obeso G, Rivas C, Blanco I, Marcos B, Garcia Delgado R, Echezarreta G, et al: Linfoma del manto folicular: estudio clinicopatológico y proliferativo de 11 casos. Med Clin (Barc) 101: 406-9. 1993.

  57. LINFOMA T PERIFÉRICO

  58. Lippman S, Miller T, Spier C, Slymen D, Grogan T: The prognostig significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 72: 436. 1988.
  59. Coiffier B, Brousse N, Peuchmaur M, et al: Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol 1: 45. 1990.

  60. LINFOMAS MALT

  61. Isaacson P, Wright DH: Extranodal malignant lymphoma arising from Mucosa Asociated Lymphoid Tissue: Cancer 53: 2515-24. 1984.
  62. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al: Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342: 575-77. 1993.
  63. Hussell T, Isaacson PG, Crabtree JE, Spencer J: The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342: 571-4. 1993.
  64. Isaacson PG, Spencer J: Is gastric lymphoma an infectious disease?. Hum Pathol 24: 569-70. 1993.
  65. Isaacson PG: Gastrointestinal lymphoma. Hum Pathol 25: 1020-9. 1994.
  66. Nakamura S, Akazawa K, Yao T, Tsuneyoshi M: Primari gastric lymphoma. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 76: 1313-24. 1995.
  67. Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, et al: Nongastrointestinal low-grade Mucosa-associated Lymphoid Tissue lymphoma: Analysis of 75 patients. J Clin oncol 17: 1254-8. 1999.

  68. LINFOMA ANAPLÁSICO DE CÉLULAS GRANDES

  69. Kadin ME, Sako D, Berliner N, FranklinW, Woda B, Borowitz M, et al: Childhood Ki-1 lymphoma presenting with skin lesions and peripheral adenopathy. Blood 68: 1042-9. 1996.
  70. Kadin ME: Anaplastic large cell lymphoma and its morphological variants. Cancer Surv 30:77-86. 1997
  71. Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, et al: Primary anaplastic large cell lymphomas in adults: clinical presentation, immunophenotype, and outcome. Blood 90: 3727-34. 1997.
  72. Chittal SM, Delsol G. The interface og Hodgkin’s disease and anaplastic large cell lymphoma. Cancer Surv 70:87-105. 1997.
  73. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263:1281-4. 1994.
  74. Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC, et al:Occurrence of the t(2;5)(p23;q35) in non-Hodgkin’s lymphoma. Blood 87:860-8. 1996.
  75. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, et al: ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91: 2076-84. 1998.
  76. Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, et al: ALK+ lymphoma: Clinico-pathological findings and outcome. Blood 93: 2697-706. 1999.
  77. Zinzani PL, Bendandi M, Martelli M, Falini B, Sabattini E, Amadori S, et al: Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 14: 955-62. 1996.
  78. Zinzani PL, Martelli M, Magagnoli M, Zaccaria A, Ronconi F, Cantonetti M, et al: Anaplastic large cell lymphoma Hodgkin’s-like: A randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood 92: 790-4. 1998.

  79. LINFOMA LINFOBLÁSTICO

  80. Levine AM, Forman SJ, Meyer PR, Koehler SC, Liebman H, Paganini-Hill A, et al: Succesful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood 61: 92-8. 1983.
  81. Morel P, Lepage E, Brice P, Dupriez B, D’Agay MF, Fenaux P, et al: Prognosis and treatment of lymphoblastic lymphoma in adults: A report on 80 patients. J Clin Oncol 10: 1078-85. 1992.
  82. Wollner N, Wachtel AE, Exelby PR, Centore D: Improved prognosis in children with intra-abdominal non-Hodgkin’s lymphoma following LSA2L2 protocol chemotherapy. Cancer 45: 3034-9. 1980.
  83. Magrath IT, Janus C, Edwadrs BK, Spiegel R, Jaffe ES, Berarad CW, et al: An effective therapy for both undifferenciated (including Burkitt’s) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63: 1102-11. 1984.

  84. LINFOMA DE BURKITT / LINFOMA BURKITT-LIKE

  85. Lopez TM, Hagemeister FB, McLaughlin et al: Small noncleaved cell lymphoma in adults: Superior results for stages I-III Disease. J Clin Oncol 8: 615-22. 1990.
  86. Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, et al: Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14: 925-34. 1996.
  87. Diviné M, Lepage E, Brière J, Pautier P, Dupriez B, Lederlin P, et al: Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controled analysis. J Clin Oncol 14: 240-248. 1996.
  88. Longo DL, Duffey PL, Jaffe ES, Raffeld M, Hubbard SM, Fisher RI, et al: Diffuse small noncleaved-cell, non-Burkitt’s lymphoma in adults: A high-grade lymphoma responsive to ProMACE-based combination chemotherapy. J Clin Oncol 12: 2153-9. 1994.
  89. Macpherson N, Lesack D, Klasa R, Horsman D, Connors JM, Barnett M, et al: Small noncleaved, non-Burkitt’s (Burkitt-like) lymphoma: Cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol 17: 1558-67. 1999.
  90.  

    LINFOMA B DE LA ZONA MARGINAL, TIPO NODAL

  91. Piris M, Rivas C, Morente M, Cruz M, Rubio C, Oliva H: Monocytoid B-cell lymphoma, a tumor related to the marginal zone. Histopathol 12:383. 1988
  92. Sheibani K, Burke JS, Swartz WG, Nademanee A, Winberg CD: Monocytoid B-Cell lymphoma. Clinicopathologic study of 21 cases of a unique type of low-grade lymphoma. Cancer 62: 1531-8. 1998.
  93. Sheibani K, Trawek T, Ben-Ezra J, Stroup R, Esteban J, Rappaport H, et al: Monocytoid B-cell lymphoma. Am J Surg Pathol 13: 902-4. 1989.
  94. Traweek T, Sheibani K, Winberg CD, Mena RR, Wu AM, Rappaport H: Monocytoid B-cell lymphoma: Its evolution and relationship to other low-grade B-cell neoplasms. Blood 73: 573-8. 1989.
  95. Weiss LM: Monocytoid B-cell lymphoma. Hum Pathol 22: 407-8. 1991.
  96. Shin SS, Sheibani K, Fishleder A, Ben-Ezra J, Bailey A, Koo CH, et al: Monocytoid B-cell lymphoma in patients with Sjögren’s Syndrome. A clinicopathologic study of 13 patients. Hum Pathol 22:422-30. 1991.
  97. Cogliatti SB, Lennert K, Hansmann ML, Zwingers TL: Monocytoid B cell lymphoma: clinical and prognostic features of 21 patients. J Clin Pathol 43: 619-25. 1990.
  98. Nizze H, Cogliatti SB, von Schilling C, Feller AC, Lennert K: Monocytoid B-cell lymphoma: morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue. Histopathol 16:403-14. 1991.
  99. Ngan BY, Warnke RA, Wilson M, Takagi K, Cleary ML, Dorfman R: Monocytoid B-cell lymphoma. A study of 36 cases. Hum Pathol 22: 409-21. 1991.
  100. Nathwani BN, Mohrmann RL, Brynes RK, Taylor CR, Hansmann ML, Sheibani K: Monocytoid B-cell lymphomas: An assessment of diagnostic criteria and a perspective of histogenesis. Hum Pathol 23:1061-71. 1992.

  101. LINFOMA LINFOPLASMOCITOIDE

  102. Dimopoulos MA, Alexanian R: Waldenström’s macroglobulinemia. Blood 83:1452-9. 1994.
  103. Harris N, Bhan A: B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunihistologic analysis and clinical correlation. Hum Pathol 16: 829. 1985.
  104. Lennert K, Tamm I, Wacker H-H: Histopathology and immunocytochemistry of lymph node biopsies in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma (suppl):157. 1991.

flred_iz.gif (833 bytes) Volver al Índice


[Objetivos] [Introducción] [Tratamientos Estándar] [L.Altamente Agresivos] [L.Foliculares] [L.Linfocitico] [L.Manto] [Linfoma T NOS] [L.MALT] [L.C.G.Mediastino] [L.Anaplásico] [L.Linfoblástico] [L.Burkitt-Like] [Linfomas Varios] [Conclusiones] [Bibliografía] [Autoevaluación]

  Fecha de última modificación: 18 agosto, 1999
Copyright. Dr. Tomás Alvaro Narajo, Dr. Llorenç Font Ferré, 1994-1999. Todos los derechos reservados